Supplemental material
Research Paper
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
Tzu-Yu Lina Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
https://orcid.org/0000-0003-1678-7779View further author information
https://orcid.org/0000-0003-1678-7779View further author information, Hsiu-Han Chanb Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0002-6843-4468View further author information
https://orcid.org/0000-0002-6843-4468View further author information, Shang-Hung Chenc National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan;d Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0002-4086-4757View further author information
https://orcid.org/0000-0002-4086-4757View further author information, Sailu Sarvagallae Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry, Indiahttps://orcid.org/0000-0001-7428-7663View further author information
https://orcid.org/0000-0001-7428-7663View further author information, Pai-Sheng Chena Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan;f Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0003-0513-1467View further author information
https://orcid.org/0000-0003-0513-1467View further author information, Mohane Selvaraj Coumare Centre for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry, Indiahttps://orcid.org/0000-0002-0505-568XView further author information
https://orcid.org/0000-0002-0505-568XView further author information, Siao Muk Chenga Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0001-8145-4220View further author information
https://orcid.org/0000-0001-8145-4220View further author information, Yung-Chieh Changa Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0002-8699-2834View further author information
https://orcid.org/0000-0002-8699-2834View further author information, Chun-Hui Linb Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwanhttps://orcid.org/0000-0002-7656-8095View further author information
https://orcid.org/0000-0002-7656-8095View further author information, Euphemia Leungg Auckland Cancer Society Research Centre and Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealandhttps://orcid.org/0000-0002-6932-3188View further author information
https://orcid.org/0000-0002-6932-3188View further author information & Chun Hei Antonio Cheunga Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan;b Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, TaiwanCorrespondence[email protected]
https://orcid.org/0000-0003-4181-1435View further author information
https://orcid.org/0000-0003-4181-1435View further author information show allRelated Research Data
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
Source:
Taylor & Francis
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
Source:
Taylor & Francis
BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells
Source:
Taylor & Francis
Linking provided by
